Pacira BioSciences Inc (PCRX)
19.50
+0.03
(+0.15%)
USD |
NASDAQ |
Dec 26, 10:18
Pacira BioSciences Free Cash Flow: 193.52M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cyclo Therapeutics Inc | -22.52M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
| Theriva Biologics Inc | -18.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 53.92M |
| Cash from Investing (Quarterly) | -52.16M |
| Cash from Financing (Quarterly) | -2.845M |
| Free Cash Flow Per Share (Quarterly) | 1.080 |
| Free Cash Flow to Equity (Quarterly) | 51.77M |
| Free Cash Flow to Firm (Quarterly) | 49.83M |
| Free Cash Flow Yield | 18.23% |